Serum Uric Acid and Risk of Coronary Heart Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|32|4125-4132

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.32, 2005-12, pp. : 4125-4132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease

By Jean-Pierre Després   Isabelle Lemieux  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2177-2198

Adis International

Access to resources Recommend Favorite

A higher ascorbic acid intake appears to be associated with a lower risk of coronary heart disease (CHD) in women

By  

Inpharma, Vol. 1, Iss. 1401, 2003-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Statins and telomere length: risk assessment and management for coronary heart disease

By Tiwari Atul  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 979-982

Informa Healthcare

Access to resources Recommend Favorite

Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease: the multicenter CARDIAC study

By Lenzen Henrike   Tsikas Dimitrios   Böger Rainer  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 45-49

Springer Publishing Company

Access to resources Recommend Favorite

The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk

By  

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3802-3816

Bentham Science Publishers

Access to resources Recommend Favorite